News Sentiment

ETON sentiment intelligence

Eton Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 36.61 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 56

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-2.4% over one week, +15.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Eton Pharmaceuticals (ETON) Could Be 18% Undervalued As Valuation Questions Build

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -2.4% Price reacting lower
Trend fit Trend active 15.9% over four weeks
Fair value 198.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 31
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 56
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 8
TradingView 8
Market source 8
Investing.com 5
simplywall.st 4
Stock Traders Daily 2
Ad-hoc-news.de 2
Investing.com Canada 2

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 13
Deals and strategy 5
Regulatory and legal 1
Analyst action 1
Capital return 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
Stock Titan Direct company coverage

Eton Pharmaceuticals (ETON) director exercises options, sells 50,000 shares in open market

Eton Pharmaceuticals director Jennifer McKie Adams exercised employee stock options for 50,000 shares at $3.78 per share and immediately sold them in open-market transactions for a weighted average price of $32.4759 per share. The sale, totaling over $1.6 million, occurred throug

Tone
Negative 38/100
Event
Market update
Published
17 Jun 2026 21:09
Source
Stock Titan
www.marketscreener.com Direct company coverage

Eton Pharmaceuticals Insider Sold Shares Worth $1,623,795, According to a Recent SEC Filing

An insider at Eton Pharmaceuticals recently sold shares valued at $1,623,795, as disclosed in a recent SEC filing. This transaction follows another significant insider sale on May 28, 2026, where shares worth $3,229,923 were sold. The company, focused on rare disease treatments,

Tone
Negative 39/100
Event
Market update
Published
17 Jun 2026 21:09
Source
www.marketscreener.com